Medicaid Provider Alert: Provider revalidation has begun and those not completing the process risk disenrollment. Check your account now to learn when your revalidation is due. More information here.

Drugs and Therapeutics Committee Meeting Results Meeting Results for: December 12, 2007

Drug Name	Review Type	Committee Recommendation	Prior Approval Status � Final Determination
Altabax	New Drug Appeal	Require Prior Approval	Prior Approval Required
Avinza	PDL Appeal	Remain Non-Preferred	Non-Preferred � PDL Class
Azor	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Byetta	New Drug Appeal	Require Prior Approval	Prior Approval Required
Cerefolin NAC	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Depakote ER	PDL Appeal	Remain Non-Preferred	Non-Preferred � PDL Class
Exforge	New Drug Appeal	Require Prior Approval	Prior Approval Required
Invega	New Drug Initial Review	Remove Prior Approval Requirement	Prior Approval requirement removed
Istalol	PDL Appeal	Remain Non-Preferred	Non-Preferred � PDL Class
Lantus	PDL Appeal	Remain Non-Preferred	Non-Preferred � PDL Class
Natelle	PDL Appeal	Remain Non-Preferred	Non-Preferred � PDL Class
Neupro	New Drug Initial Review	Remove Prior Approval Requirement	Prior Approval requirement removed
Perforomist	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Pylera	New Drug Appeal	Remove Prior Approval Requirement	Prior Approval Required
Veramyst	New Drug Appeal	Require Prior Approval	Prior Approval Required
Xibrom	PDL Appeal	Remain Non-Preferred	Non-Preferred � PDL Class
Xyzal	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Zinotic	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Zyflo CR	New Drug Initial Review	Require Prior Approval	Prior Approval Required

Footer